CER-1236 in Patients With Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), and Myelofibrosis (MF)
- Status
- RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Acute Myeloid Leukemia
Related studies linked through entity extraction aliases.
Veneclax, Chidaniline Combined With Azacitidine Followed by Decitabine + MAG Regimen in the Treatment of Elderly Untreated AML
- Status
- RECRUITING
- Phase
- PHASE2
Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete Remission
- Status
- RECRUITING
- Phase
- PHASE2
A Study of XS-04 in Patients with Relapsed or Refractory Hematologic Malignancies
- Status
- RECRUITING
- Phase
- PHASE1
Study on the Efficacy and Safety of the TmBU Conditioning Regimen in High-risk or Relapsed/Refractory Acute Leukemia
- Status
- RECRUITING
- Phase
- PHASE2
Vedolizumab Plus Post-transplant Cyclophosphamide and Short Course Tacrolimus for the Prevention of Graft Versus Host Disease in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation After Reduced Intensity Conditioning
- Status
- RECRUITING
- Phase
- PHASE2
A Prospective Trial of Dalbavancin-Based Prophylaxis in Children and Adolescents With High-Risk Leukemia
- Status
- RECRUITING
- Phase
- PHASE1
Interferon-alpha As Maintenance Therapy for Favorable-risk Acute Myeloid Leukemia
- Status
- RECRUITING
- Phase
- PHASE3
Testing the Combination of Targeted Radiotherapy With Anti-Cancer Drugs, Venetoclax and ASTX-727, to Improve Outcomes for Adults With Newly Diagnosed Acute Myeloid Leukemia
- Status
- SUSPENDED
- Phase
- PHASE1
Epidemiology of Infection in Acute Myeloid Leukemia (AML)
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Expectations of Patients in Palliative Situation
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Olutasidenib, Venetoclax, and Azacitidine in IDH1 Mutated Newly Diagnosed Acute Myeloid Leukemia Patients Eligible for Intensive Induction Chemotherapy
- Status
- RECRUITING
- Phase
- PHASE2
Oral-ATO for TP53-mutated Myeloid Malignancies
- Status
- RECRUITING
- Phase
- PHASE2
Dose Escalation and Expansion of Ziftomenib in Combination With Quizartinib in Acute Myeloid Leukemia
- Status
- RECRUITING
- Phase
- PHASE1
A Clinical Study to Explore the Safety and Efficacy of CD33 CAR-T Cell in Relapsed/Refractory Acute Myeloid Leukemia
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
BN104 in Combination With Chemotherapy or Targeted Agents for Acute Myeloid Leukemia
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Chiglitazar Sodium Combined With Venetoclax and Azacitidine (CVA) for the Treatment of R/R AML
- Status
- RECRUITING
- Phase
- PHASE1
Using Gilteritinib to Keep People With Acute Myeloid Leukemia Cancer-free After a Stem Cell Transplant
- Status
- COMPLETED
- Phase
- N/A
IMPACT-AML: A Randomized Pragmatic Clinical Trial for Relapsed or Refractory Acute Myeloid Leukemia.
- Status
- RECRUITING
- Phase
- PHASE3
Evaluating the Effects of Hemoglobin Threshold-specific Packed Red Blood Cell Transfusions on Quality of Life and Functional Outcomes in Patients With High-grade Myeloid Neoplasms, Acute Myeloid Leukemia, or B Acute Lymphoblastic Lymphoma/Leukemia
- Status
- RECRUITING
- Phase
- NA